Radiologists Countersue Former Colleague over Delayed $2M Payout in Sale to Private Equity

Why It Matters

The dispute highlights governance challenges and financial risks inherent in physician‑owned practices selling to private equity, potentially influencing future deal structures and litigation strategies in the healthcare sector.

Key Takeaways

• Southtowns Radiology sued former partner Gregory Ball over $2 M payout
• Ball alleges he was forced to sell his 10% stake for $313K
• The practice sold its imaging centers to Rezolut for $20 M in 2023
• Judge dismissed most of Ball’s fraud and malpractice claims last December
• Countersuit seeks damages for defending against what doctors call a frivolous claim

Pulse Analysis

Private‑equity investment in radiology has accelerated over the past decade, driven by the sector’s high‑margin imaging services and predictable cash flows. Firms like Rezolut target established physician groups, offering capital for expansion while extracting value through operational efficiencies. However, these transactions often involve complex ownership structures and redemption clauses that can become flashpoints when partners disagree on valuation or timing. The Southtowns Radiology case underscores how the lure of a sizable exit—$20 million for a 70‑year‑old practice—can clash with individual physicians’ expectations of fair compensation.

At the heart of the litigation is a dispute over a redemption agreement that required the practice to pay Ball $313,000 before the sale closed, a figure Ball contends was far below his true entitlement. While the court dismissed most of his fraud and malpractice allegations, the countersuit filed by the remaining physicians seeks to enforce the $2 million payout they believe is owed. The case illustrates the importance of clear governance provisions, such as supermajority voting thresholds and transparent valuation methods, to mitigate post‑sale conflicts. Legal counsel for physician groups increasingly advise robust buy‑sell agreements and independent valuations to protect minority shareholders.

The broader implication for the healthcare market is a heightened awareness of litigation risk in PE‑backed deals. Investors may respond by tightening due diligence, incorporating escrow mechanisms, or offering earn‑out structures that align incentives. For radiology practices, the episode serves as a cautionary tale: aligning partnership agreements with exit strategies is essential to avoid costly disputes that can erode value and distract from patient care. As private equity continues to shape the radiology landscape, both buyers and sellers must prioritize clear contractual language and dispute‑resolution pathways to sustain growth and confidence in the sector.